What does the “start low and go slow” approach in opioid prescribing emphasize?

The “start low and go slow” approach in opioid prescribing emphasizes the importance of initiating treatment with low doses and gradually increasing them as needed. This strategy is crucial for minimizing the risk of adverse effects and overdose, especially in patients who may be opioid naïve or have complex medical histories.

By starting with a low dose, healthcare providers can assess the patient’s response to the medication and adjust the dosage based on their individual tolerance and the presence of any side effects. Gradual titration also enhances patient safety by reducing the likelihood of respiratory depression and other serious complications. This approach aligns with best practices in pain management and ensures that opioids are used judiciously, balancing the need for effective pain relief while minimizing risks associated with higher doses.

In contrast, beginning therapy at high doses could lead to significant safety concerns, and eliminating dosage adjustments does not allow for the necessary monitoring of the patient's response. Similarly, the exclusive use of non-opioid medications does not fit within the context of opioid prescribing and overlooks situations where opioids may be indicated for pain management.